Paylocity Holding Corporation (PCTY)
USD 194.4
(-4.27%)
USD 194.4
(-4.27%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 384.59 Million | 282.72 Million | 155.05 Million | 124.85 Million | 112.65 Million | 115.03 Million |
| Net Income | 206.76 Million | 140.82 Million | 90.77 Million | 70.81 Million | 64.45 Million | 53.82 Million |
| Depreciation & Amortization | 76.42 Million | 60.86 Million | 50.21 Million | 42.97 Million | 37.91 Million | 34.56 Million |
| Deferred income taxes | 27.83 Million | 13.54 Million | -7.18 Million | -13.64 Million | 2.75 Million | 4.13 Million |
| Stock-based compensation | 146.03 Million | 147.3 Million | 96.2 Million | 63.05 Million | 47.49 Million | 38.76 Million |
| Change in working capital | -68.61 Million | -77.32 Million | -76.15 Million | -39.81 Million | -38.98 Million | -14.76 Million |
| Other non-cash items | 300.8 Million | -2.48 Million | 1.19 Million | 1.46 Million | -978 Thousand | -1.49 Million |
| Investing Cash Flow | -101.89 Million | -220.16 Million | -479.77 Million | 48.42 Million | -48.75 Million | -43.34 Million |
| Investments in PPE | -78.75 Million | -66.91 Million | -52.58 Million | -38.05 Million | -42.29 Million | -31.42 Million |
| Acquisitions | -12.03 Million | -45 Million | -107.57 Million | -14.99 Million | -16.71 Million | -20.14 Million |
| Investment purchases | -304.46 Million | -598.89 Million | -433.96 Million | 28.59 Million | -400.34 Million | -250.68 Million |
| Sales/Maturities of investments | 294.43 Million | 446.75 Million | 116.84 Million | 101.46 Million | 410.59 Million | 246.24 Million |
| Other Investing Activities | -1.07 Million | 43.9 Million | -2.5 Million | -28.59 Million | -15.46 Million | 12.66 Million |
| Financing Cash Flow | 141.65 Million | -1.43 Billion | 2.17 Billion | 280.47 Million | 2.09 Million | 114.72 Million |
| Debt repayment | - | - | -50 Million | -100 Million | -100 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -150 Million | -88.31 Million | -69.76 Million | -64.19 Million | -38.94 Million | -34.99 Million |
| Common Stock Issuance | 19.14 Million | 16.91 Million | 146 Thousand | 12.36 Million | 8.9 Million | 6.06 Million |
| Other Financing Activities | 272.5 Million | -1.36 Billion | 2.36 Billion | 484.14 Million | 202.09 Million | 143.64 Million |
| Accounts receivables | -8.18 Million | -9.4 Million | -7.6 Million | -1.65 Million | -732 Thousand | -1.18 Million |
| Accounts payables | 2.42 Million | -1.55 Million | 2.55 Million | 2.39 Million | -806 Thousand | -75 Thousand |
| Inventory | - | 14.42 Million | - | 16.29 Million | 17.5 Million | 14.01 Million |
| Other working capital | -62.85 Million | -80.78 Million | -71.1 Million | -56.85 Million | -54.94 Million | -27.51 Million |
| Cash at beginning of period | 288.76 Million | 3.79 Billion | 1.94 Billion | 1.49 Billion | 1.42 Billion | 1.23 Billion |
| Cash at end of period | 401.81 Million | 2.42 Billion | 3.79 Billion | 1.94 Billion | 1.49 Billion | 1.42 Billion |
| Capital Expenditure | -78.75 Million | -66.91 Million | -52.58 Million | -38.05 Million | -42.29 Million | -31.42 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 113.04 Million | -1.37 Billion | 1.84 Billion | 453.74 Million | 65.99 Million | 186.41 Million |
| Free Cash Flow | 305.84 Million | 215.8 Million | 102.46 Million | 86.79 Million | 70.36 Million | 83.61 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 206.76 Million | 48.81 Million | 85.31 Million | 38.11 Million | 34.51 Million | 140.82 Million |
| Depreciation & Amortization | 76.42 Million | 20.64 Million | 20.27 Million | 18.38 Million | 17.12 Million | 60.86 Million |
| Deferred income taxes | 27.83 Million | 9.29 Million | 3.31 Million | 9.83 Million | 5.39 Million | 13.54 Million |
| Stock-based compensation | 146.03 Million | 28.86 Million | 34.95 Million | 43.2 Million | 39 Million | 147.3 Million |
| Change in working capital | -68.61 Million | -30 Million | 23.66 Million | -29.4 Million | -32.87 Million | -77.32 Million |
| Other non-cash items | 300.8 Million | 67.69 Million | 80.05 Million | -5.06 Million | -1.02 Million | -2.48 Million |
| Investing Cash Flow | -101.89 Million | -25.48 Million | -14.22 Million | -52.78 Million | -9.4 Million | -220.16 Million |
| Investments in PPE | -78.75 Million | -22.55 Million | -20.57 Million | -17.97 Million | -17.64 Million | -66.91 Million |
| Acquisitions | -12.03 Million | 29.48 Million | -16 Thousand | -27.3 Million | -14.19 Million | -45 Million |
| Investment purchases | -304.46 Million | -72.79 Million | -66.85 Million | -72.24 Million | -92.56 Million | -598.89 Million |
| Sales/Maturities of investments | 294.43 Million | 71.72 Million | 71.86 Million | 49.63 Million | 101.21 Million | 446.75 Million |
| Other Investing Activities | -1.07 Million | -1.07 Million | 1.36 Million | 15.11 Million | 13.78 Million | 43.9 Million |
| Financing Cash Flow | 141.65 Million | -785.87 Million | 297.6 Million | 752.31 Million | -122.4 Million | -1.43 Billion |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -150 Million | -150 Million | -10.66 Million | -6.56 Million | -28.82 Million | -88.31 Million |
| Common Stock Issuance | 19.14 Million | 9.6 Million | - | 9.53 Million | - | 16.91 Million |
| Other Financing Activities | 272.5 Million | -645.48 Million | 297.6 Million | 742.78 Million | -93.57 Million | -1.36 Billion |
| Accounts receivables | -8.18 Million | 1.72 Million | -2.86 Million | -2.25 Million | -4.8 Million | -9.4 Million |
| Accounts payables | 2.42 Million | 2.97 Million | -1.68 Million | -438 Thousand | 1.56 Million | -1.55 Million |
| Inventory | - | 25.6 Million | - | -10.95 Million | -14.65 Million | 14.42 Million |
| Other working capital | -62.85 Million | -34.7 Million | 28.2 Million | -15.75 Million | -14.98 Million | -80.78 Million |
| Cash at beginning of period | 288.76 Million | 492.69 Million | 366.9 Million | 2.35 Billion | 2.42 Billion | 3.79 Billion |
| Cash at end of period | 401.81 Million | 401.81 Million | 492.69 Million | 3.12 Billion | 2.35 Billion | 2.42 Billion |
| Capital Expenditure | -78.75 Million | -22.55 Million | -20.57 Million | -17.97 Million | -17.64 Million | -66.91 Million |
| Effect of forex changes on cash | - | 658.85 Million | - | -658.85 Million | - | - |
| Net cash flow / Change in cash | 113.04 Million | -90.88 Million | 125.79 Million | 774.6 Million | -69.66 Million | -1.37 Billion |
| Free Cash Flow | 305.84 Million | 57.3 Million | 146.95 Million | 57.09 Million | 44.49 Million | 215.8 Million |
MEDX
ALD
RSI
2750
BPPPF
IVP